What This Cytokinetics Insider Sale Signals Stock Surge
A Cytokinetics insider sale coincides with a stunning stock move. This article breaks down what the trade might signa...
Identify the Dividend Aristocrats ETF with the lowest fees and understand how fee selection affects long-term performance.
27,609 articlesA Cytokinetics insider sale coincides with a stunning stock move. This article breaks down what the trade might signa...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
A bush pilot fights the seizure of his plane after a single alcohol-related incident, arguing the forfeiture violates...
Paladin Power unveiled a non-lithium, solid-state graphene energy storage system that promises safer, faster deployme...
Major asset managers are taking stakes in DeFi tokens, a move that marks a shift from speculation to strategic exposu...
Warner Bros. Discovery says it is reviewing Paramount's new bid while maintaining its Netflix-backed proposal for War...
The latest Freddie Mac survey shows the 30-year fixed rate dipping under 6% for the first time in years, signaling po...
AI's rapid growth in 2026 is real, but the panic around job loss and market collapse is overblown. This report explai...
When insider-like conviction meets market risk, funds can double down on a stock. This analysis explains why Black Cy...
XRP is testing a key technical juncture, with a weekly close above the 200 EMA and $1.55 potentially weakenting the b...
Marvell Technology shows signs of narrowing Broadcom's AI revenue lead as data-center demand accelerates, sparking re...
Forecasting Tesla is never dull. This article lays out base, bull, and bear scenarios for the next five years, with a...